The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands
Open accessAbstract
The targeted delivery of nanoparticles to solid tumors is one of the most important and challenging problems in cancer nanomedicine, but the detailed delivery mechanisms and design principles are still not well understood. Here we report quantitative tumor uptake studies for a class of elongated gold nanocrystals (called nanorods) that are covalently conjugated to tumor-targeting peptides. A major advantage in using gold as a "tracer" is that the accumulated gold in tumors and other organs can be quantitatively determined by elemental mass spectrometry (gold is not a natural element found in animals). Thus, colloidal gold nanorods are stabilized with a layer of polyethylene glycols (PEGs) and are conjugated to three different ligands: (i) a single-chain variable fragment (ScFv) peptide that recognizes the epidermal growth factor receptor (EGFR); (ii) an amino terminal fragment (ATF) peptide that recognizes the urokinase plasminogen activator receptor (uPAR); and (iii) a cyclic RGD peptide that recognizes the a(v)β(3) integrin receptor. Quantitative pharmacokinetic and biodistribution data show that these targeting ligands only marginally improve the total gold accumulation in xenograft tumor models in comparison with nontargeted controls, but their use could greatly alter the intracellular and extracellular nanoparticle distributions. When the gold nanorods are administered via intravenous injection, we also find that active molecular targeting of the tumor microenvironments (e.g., fibroblasts, macrophages, and vasculatures) does not significantly influence the tumor nanoparticle uptake. These results suggest that for photothermal cancer therapy, the preferred route of gold nanorod administration is intratumoral injection instead of intravenous injection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
Huang, X., El-Sayed, I. H., Qian, W., & El-Sayed, M. A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057254a · Cited by 5,436
Self-citationPreparation and Growth Mechanism of Gold Nanorods (NRs) Using Seed-Mediated Growth Method
Nikoobakht, B., & El-Sayed, M. A. (2003) · Chemistry of Materials · doi:10.1021/cm020732l · Cited by 5,069
Self-citationIn vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Self-citationCancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Self-citationTherapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Self-citationShape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc727 · Cited by 1,777
Cited by
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15237h · Cited by 3,550
Self-citationGold nanoparticles in biomedical applications: recent advances and perspectives
Dykman, L., & Khlebtsov, N. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15166e · Cited by 1,961
The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy
Doane, T. L., & Burda, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15260f · Cited by 1,098
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Etheridge, M. L., Campbell, S. A., Erdman, A. G., Haynes, C. L., Wolf, S. M., & McCullough, J. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.013 · Cited by 1,088
Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles
Abadeer, N. S., & Murphy, C. J. (2016) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b11232 · Cited by 919
SERS Nanoparticles in Medicine: From Label-Free Detection to Spectroscopic Tagging
Lane, L. A., Qian, X., & Nie, S. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00265 · Cited by 873
Self-citationKalyane, D., Raval, N., Maheshwari, R., Tambe, V., Kalia, K., & Tekade, R. K. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.01.066 · Cited by 849
Gold nanostars: surfactant-free synthesis, 3D modelling, and two-photon photoluminescence imaging
Yuan, H., Khoury, C. G., Hwang, H., Wilson, C. M., Grant, G. A., & Vo-Dinh, T. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/7/075102 · Cited by 777
Wang, Y., Zhou, K., Huang, G., Hensley, C., Huang, X., Ma, X., Zhao, T., Sumer, B. D., DeBerardinis, R. J., & Gao, J. (2014) · Nature Materials · doi:10.1038/nmat3819 · Cited by 773
Self-citationHuang, P., Lin, J., Li, W., Rong, P., Wang, Z., Wang, S., Wang, X., Sun, X., Aronova, M., Niu, G., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201308986 · Cited by 672
Size Matters: Gold Nanoparticles in Targeted Cancer Drug Delivery
Dreaden, E. C., Austin, L. A., Mackey, M. A., & El-Sayed, M. A. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.21 · Cited by 651
Self-citationThe Quest for Shape Control: A History of Gold Nanorod Synthesis
Lohse, S. E., & Murphy, C. J. (2013) · Chemistry of Materials · doi:10.1021/cm303708p · Cited by 649
Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency
Sykes, E. A., Chen, J., Zheng, G., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn500299p · Cited by 635
Gold Nanoparticles in Cancer Treatment
Sztandera, K., Gorzkiewicz, M., & Klajnert-Maculewicz, B. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00810 · Cited by 607
Liu, J., Yu, M., Zhou, C., Yang, S., Ning, X., & Zheng, J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja401612x · Cited by 597
Yuan, H., Fales, A. M., & Vo-Dinh, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304180y · Cited by 523
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
Wang, S., Huang, P., Nie, L., Xing, R., Liu, D., Wang, Z., Lin, J., Chen, S., Niu, G., Lu, G., et al. (2013) · Advanced Materials · doi:10.1002/adma.201204623 · Cited by 503
Recent advances in selective photothermal therapy of tumor
Zhao, L., Zhang, X., Wang, X., Guan, X., Zhang, W., & Ma, J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01080-3 · Cited by 445
Applications of Colloidal Inorganic Nanoparticles: From Medicine to Energy
Lohse, S. E., & Murphy, C. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307589n · Cited by 430
Peng, C., Zheng, L., Chen, Q., Shen, M., Guo, R., Wang, H., Cao, X., Zhang, G., & Shi, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.052 · Cited by 391
Bridging Bio–Nano Science and Cancer Nanomedicine
Björnmalm, M., Thurecht, K. J., Michael, M., Scott, A. M., & Caruso, F. (2017) · ACS Nano · doi:10.1021/acsnano.7b04855 · Cited by 382
Enhanced Tumor Accumulation of Sub‐2 nm Gold Nanoclusters for Cancer Radiation Therapy
Zhang, X., Chen, J., Luo, Z., Wu, D., Shen, X., Song, S., Sun, Y., Liu, P., Zhao, J., Huo, S., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300189 · Cited by 373
Functionalizing Framework Nucleic‐Acid‐Based Nanostructures for Biomedical Application
Zhang, T., Tian, T., & Lin, Y. (2022) · Advanced Materials · doi:10.1002/adma.202107820 · Cited by 368
Nanoparticles for combination drug therapy
Ma, L., Kohli, M., & Smith, A. (2013) · ACS Nano · doi:10.1021/nn405674m · Cited by 367
Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability
Gigliobianco, M. R., Casadidio, C., Censi, R., & Di Martino, P. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030134 · Cited by 366
Liu, X., Chen, Y., Li, H., Huang, N., Jin, Q., Ren, K., & Ji, J. (2013) · ACS Nano · doi:10.1021/nn402201w · Cited by 356
Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology
Liu, J., Yu, M., Zhou, C., & Zheng, J. (2013) · Materials Today · doi:10.1016/j.mattod.2013.11.003 · Cited by 351
One-Dimensional Metal Nanostructures: From Colloidal Syntheses to Applications
Huo, D., Kim, M. J., Lyu, Z., Shi, Y., Wiley, B. J., & Xia, Y. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00745 · Cited by 335
Silica Nanorattle–Doxorubicin-Anchored Mesenchymal Stem Cells for Tumor-Tropic Therapy
Li, L., Guan, Y., Liu, H., Hao, N., Liu, T., Meng, X., Fu, C., Li, Y., Qu, Q., Zhang, Y., et al. (2011) · ACS Nano · doi:10.1021/nn202399w · Cited by 327
The Gold Standard: Gold Nanoparticle Libraries To Understand the Nano–Bio Interface
Alkilany, A. M., Lohse, S. E., & Murphy, C. J. (2013) · Accounts of Chemical Research · doi:10.1021/ar300015b · Cited by 324
Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines
Kunjachan, S., Pola, R., Gremse, F., Theek, B., Ehling, J., Moeckel, D., Hermanns-Sachweh, B., Pechar, M., Ulbrich, K., Hennink, W. E., et al. (2014) · Nano Letters · doi:10.1021/nl404391r · Cited by 317
Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies
Wang, B., Wang, J.-H., Liu, Q., Huang, H., Chen, M., Li, K., Li, C., Yu, X.-F., & Chu, P. K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.066 · Cited by 311
Uptake of Engineered Gold Nanoparticles into Mammalian Cells
Dykman, L. A., & Khlebtsov, N. G. (2014) · Chemical Reviews · doi:10.1021/cr300441a · Cited by 292
A Gold/Silver Hybrid Nanoparticle for Treatment and Photoacoustic Imaging of Bacterial Infection
Kim, T., Zhang, Q., Li, J., Zhang, L., & Jokerst, J. V. (2018) · ACS Nano · doi:10.1021/acsnano.8b01362 · Cited by 284
Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer
Llevot, A., & Astruc, D. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15080d · Cited by 281
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
Baeza, A., Colilla, M., & Vallet-Regí, M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.953051 · Cited by 270
Zhang, X., Chen, J., Min, Y., Park, G. B., Shen, X., Song, S., Sun, Y., Wang, H., Long, W., Xie, J., et al. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201302312 · Cited by 263
Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization
Schuemann, J., Berbeco, R., Chithrani, D. B., Cho, S. H., Kumar, R., McMahon, S. J., Sridhar, S., & Krishnan, S. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.09.032 · Cited by 253
Biscaglia, F., Quarta, S., Villano, G., Turato, C., Biasiolo, A., Litti, L., Ruzzene, M., Meneghetti, M., Pontisso, P., & Gobbo, M. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.109762 · Cited by 25
Metadata
- Authors
- Huang, X., Peng, X., Wang, Y., Wang, Y., Shin, D. M., El-Sayed, M. A., & Nie, S.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-09-23
- Volume
- 4
- Issue
- 10
- Pages
- 5887-5896
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W1969471545
- Cited by
- 427
- References
- 54
- FWCI
- 23.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.